Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  London Stock Exchange  >  Ark Therapeutics Group plc       GB0034251727

ARK THERAPEUTICS GROUP PLC
Mes dernières consult.
Most popular
Report
 SummaryNewsCalendarCompanyFinancialsConsensusRevisions 
Company
Premier Veterinary Group Plc provides veterinary health care services.It operates through two businesses: the operation of veterinary practices and the provision of products and services to third party practices through its subsidiary Premier Vet Alliance.The company also administers a small animal... 
Sector
Pharmaceuticals
Calendar
02/01 | 12:30pmShareholder meeting
More about the company
Latest news on ARK THERAPEUTICS GROUP PLC
05/18PREMIER VETERINARY GROUP PLC : half-yearly earnings release
03/10 DIRECTOR DEALINGS : Three Premier Veterinary Directors Sell Shares
03/03 PREMIER VETERINARY : Selling Premier Buying Group To Fund US Expansion
02/24 PREMIER VETERINARY : UK Shareholder Meetings Calendar - Next 7 Days
02/16 PREMIER VETERINARY : Signs Up New US Midwest Distribution Partner
01/31 PREMIER VETERINARY : Agrees New Loan Note As Pets On Plans Rise In 2016
2016DJPremier Veterinary Signs Dutch Cooperation Agreement With Zoetis
2016 PREMIER VETERINARY : Appointment of Broker
2016 PREMIER VETERINARY : Further Major Agreement Signed in the US
2016 PREMIER VETERINARY : Director's Dealings
More news
Sector news : Generic Pharmaceuticals
05:13aDJSANOFI : Philippines Probes Dengue Vaccination Drive That Went Ahead Despite War..
02:24aDJSANOFI : Philippines Probes Vaccination Drive Amid Red Flags
12/17 TEVA PHARMACEUTICAL INDUSTRIES : Strike over Teva Pharm job cuts briefly shuts d..
12/16 PROCTER & GAMBLE : P&G appoints Peltz to board despite losing proxy battle
12/16 NELSON PELTZ : P&G appoints Peltz to board despite losing proxy battle
More sector news : Generic Pharmaceuticals
Income Statement Evolution
Consensus
 
Mean consensus BUY
Number of Analysts 1
Average target price 1,08  GBP
Spread / Average Target 196%
EPS Revisions
Managers
NameTitle
Dominic Stephen Tonner Chief Executive Officer & Executive Director
Juliet Thompson Independent Non-Executive Chairman
Will Evans Chief Financial Officer
Graham Dick Independent Non-Executive Director
Rajan Uppal Executive Director